Skip to content

Clinical trials

Ovarian Neoplasms trials in the United States with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Unknown status Country / region: United States Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20024
20041
20052
20064
20071
20084
20091
20102
20111
20123
20131
20143
20154
20163
20174
20183
20192
20203
20217
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status69

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital4
Gynecologic Oncology Group3
Herbert Irving Comprehensive Cancer Center3
AltaRex2
Loyola University2
M.D. Anderson Cancer Center2
NGM Biopharmaceuticals, Inc2
The University of Texas Health Science Center, Houston2
U.S. Army Medical Research and Development Command2
University of Virginia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms69
Fallopian Tube Neoplasms22
Breast Neoplasms18
Carcinoma, Ovarian Epithelial16
Endometrial Neoplasms16
Colorectal Neoplasms15
Pancreatic Neoplasms15
Uterine Cervical Neoplasms11
Prostatic Neoplasms8
Stomach Neoplasms8

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.